Asklepios BioPharma Launches New Biotech Actus Therapeutics Post author:Sam Post published:December 14, 2017 Post category:BioPharma Asklepios BioPharma is forming a new biotech portfolio company, Actus Therapeutics. Source: BioSpace You Might Also Like Cancer Biotech G1 Therapeutics Files for $115 Million IPO April 17, 2017 Neurotrope Poaches Forest Lab Exec to Be CEO December 17, 2017 Integer CEO Steps Down March 29, 2017
